Company intelligence / Profile preview

Inofab Health

Ankara, Turkey

Ownership: Private
Development stage: Other

Overview

Inofab Health is a digital respiratory care technology company whose platform enables patients to conduct lung function tests at home with ultrasonic spirometers and track lung health via mobile apps. Its technology is used for managing chronic respiratory conditions and has been recognized internationally for innovation. The company's products are used in digital respiratory care, disease management, and inhaler solutions. Inofab Health was acquired by Carbon Health in 2022 and subsequently by Clario in November 2023[1][4][5].

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Inofab Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inofab Health.

Explore the full profile